EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Exploring Healthcare Continuity in Pediatric‐Onset Multiple Sclerosis in the United States

Aaron W Abrams iD, Michael Waltz, Jonathan Race, T Charles Casper, Claudia Gambrah-Lyles, Kimberly O'Neill, Akash Virupakshaiah, Kristen S Fisher, Melissa A Wright iD, Kelsey E Poisson, Eva-Chava M Bernfeld, Gregory Aaen und 20 weitere

Annals of the Child Neurology Society · 2026-09 · 4 (3) · 177-187

DOI: 10.1002/cns3.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of the Child Neurology Society, online erschienen am 25.06.2026. Verfasst von Aaron W Abrams und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Cleveland Clinic Cleveland Ohio USA. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Little is known about shifting from pediatric to adult‐focused multiple sclerosis (MS) care. This study aims to explore transition of care and follow‐up in the US pediatric‐onset MS (POMS) population.

Methods

Surveys were distributed to 10 sites in the US Network of Pediatric MS Centers (US NPMSC) about transition‐of‐care practices. A cohort of POMS/clinically isolated syndrome (CIS) at 12 US NPMSC sites was analyzed. The primary comparison was between < 18 and ≥ 18‐years of age. The primary outcome was 1‐ and 2‐year lapse in last follow‐up visit, measured from last recorded database visit to data lock date or, if ≥ 18 years of age, up to 1 year after a patient reached their site's typical transition age, if earlier. Secondary outcomes were baseline factors associated with follow‐up lapse. The model was adjusted for preidentified confounders.

Results

Compared with < 18 years, age ≥ 18 was associated with greater hazard of 1‐ and 2‐year follow‐up lapse. In POMS/CIS, the estimated hazard was 1.61 for 1‐year lapse (95% confidence interval [CI] 1.32–1.97, p < 0.001) and 1.40 for 2‐year lapse (95% CI 1.11–1.76, p = 0.004). In POMS‐only, the estimated hazard was 1.70 for 1‐year lapse (95% CI 1.33–2.18, p < 0.001) and 1.49 for 2‐year lapse (95% CI 1.11–1.99, p = 0.007). Platform injectable disease‐modifying therapy was associated with greater and intravenous with lesser hazard of lapse in follow‐up, while MS was associated with lower hazard than CIS.

Conclusion

Variable transition‐of‐care practices and barriers were reported by major US POMS centers. Before typical transition age, age ≥ 18 was associated with greater hazard of 1‐ and 2‐year follow‐up lapse than < 18. Developing standardized, targeted transition‐of‐care practices in POMS may be important.

Schlagwörter

Stichwörter der Autor:innen

healthcare continuitymultiple sclerosispediatrictransition

Autor:innen und Institutionen

  • Department of Neurology Cleveland Clinic Cleveland Ohio USA.
  • Department of Pediatrics University of Utah Salt Lake City Utah USA.
  • Department of Neurology Washington University in Saint Louis St Louis Missouri USA.
  • Department of Neurology New York University Langone Health New York New York USA.
  • Department of Neurology, UCSF Weill Institute for Neurosciences University of California San Francisco San Francisco California USA.
  • Department of Neurology Texas Children's Hospital Houston Texas USA.

ORCID-Profile: Aaron W Abrams, Melissa A Wright, Grace Y Gombolay

Zitieren

APA

Abrams, A. W., Waltz, M., Race, J., Casper, T. C., Gambrah-Lyles, C., O'Neill, K., Virupakshaiah, A., Fisher, K. S., Wright, M. A., Poisson, K. E., Bernfeld, E. M., Aaen, G., Benson, L. A., Chitnis, T., Francisco, C., Gombolay, G. Y., Gorman, M. P., Graves, J. S., Krupp, L., …, & US Network of Pediatric MS Centers (2026). Exploring Healthcare Continuity in Pediatric‐Onset Multiple Sclerosis in the United States. Annals of the Child Neurology Society, 4(3), 177-187. https://doi.org/10.1002/cns3.70070

Vancouver

Abrams AW, Waltz M, Race J, Casper TC, Gambrah-Lyles C, O'Neill K, et al. Exploring Healthcare Continuity in Pediatric‐Onset Multiple Sclerosis in the United States. Annals of the Child Neurology Society. 2026;4(3):177-187. doi:10.1002/cns3.70070

BibTeX
@article{Abrams2026,
  author = {Abrams, Aaron W and Waltz, Michael and Race, Jonathan and Casper, T Charles and Gambrah-Lyles, Claudia and O'Neill, Kimberly and Virupakshaiah, Akash and Fisher, Kristen S and Wright, Melissa A and Poisson, Kelsey E and Bernfeld, Eva-Chava M and Aaen, Gregory and Benson, Leslie A and Chitnis, Tanuja and Francisco, Carla and Gombolay, Grace Y and Gorman, Mark P and Graves, Jennifer S and Krupp, Lauren and Lotze, Timothy E and Mar, Soe and Ness, Jayne and Rensel, Mary and Rodriguez, Moses and Schreiner, Teri and Shukla, Nikita and Tillema, Jan-Mendelt and Weinstock-Guttman, Bianca and Wheeler, Yolanda and Waubant, Emmanuelle and Rose, John and US Network of Pediatric MS Centers, US Network of Pediatric MS Centers},
  title = {Exploring Healthcare Continuity in Pediatric‐Onset Multiple Sclerosis in the United States},
  journal = {Annals of the Child Neurology Society},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {177--187},
  doi = {10.1002/cns3.70070}
}
Kostenlos starten →